Release Date: 30/12/20 13:24 Summary: Issue of Options - Appendix 3G Price Sensitive: No Download Document 506.26KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%